References
- 1. Pasricha JS, Khaitan BK, Dash S. Pigmentary disorders in India. Dermatol Clin. 2007;25(3):343-52.10.1016/j.det.2007.05.00417662900
- 2. Ortonne JP, Arellano I, Berneburg M, Cestari T, Chan H, Grimes P, et al. A global survey of the role of ultra-violet radiation and hormonal influences in the development of melasma. J Eur Acad Dermatol Venereol. 2009;23(11):1254-62.10.1111/j.1468-3083.2009.03295.x19486232
- 3. Jang YH, Lee JY, Kang HY, Lee ES, Kim YC. Oestrogen and progesterone receptor expression in melasma: an immunohistochemical analysis. J Eur Acad Dermatol Venereol. 2010;24(11):1312-6.10.1111/j.1468-3083.2010.03638.x20337826
- 4. Roberts WE. Pollution as a risk factor for the development of melasma and other skin disorders of facial hyperpigmentation - is there a case to be made? J Drugs Dermatol. 2015;14(4):337-41.
- 5. Lee DB, Suh HS, Choi YS. A comparative study of lowfluence 1,064 nm Q-Switched Nd: YAG laser with or without chemical peeling using Jessner’s solution in melasma patients. J Cosmet Laser Ther. 2014;16(6):264-70.10.3109/14764172.2013.86420124245978
- 6. Taylor CR, Anderson RR. Ineffective treatment of refractory melasma and postinflammatory hyperpigmentation by Q‐switched ruby laser. J Dermatol Surg Oncol. 1994;20(9):592-7.10.1111/j.1524-4725.1994.tb00152.x8089359
- 7. Moreno Arias GA, Ferrando J. Intense pulsed light for melanocytic lesions. Dermatol Surg. 2001;27(4):397-400.10.1046/j.1524-4725.2001.00315.x11298715
- 8. Wang CC, Hui CY, Sue YM, Wong WR, Hong HS. Intense pulsed light for the treatment of refractory melasma in Asian persons. Dermatol Surg. 2004;30(9):1196-200.10.1111/j.1524-4725.2004.30371.x
- 9. Jutley GS, Rajaratnam R, Halpern J, Salim A, Emmett C. Systematic review of randomized controlled trials on interventions for melasma: an abridged Cochrane review. J Am Acad Dermatol. 2014;70(2):369-73.10.1016/j.jaad.2013.07.04424438951
- 10. Chan R, Park KC, Lee MH, Lee ES, Chang SE, Leow YH, et al. A randomized controlled trial of the efficacy and safety of a fixed triple combination (fluocinolone acetonide 0· 01%, hydroquinone 4%, tretinoin 0· 05%) compared with hydroquinone 4% cream in Asian patients with moderate to severe melasma. Br J Dermatol. 2008;159(3):697-703.10.1111/j.1365-2133.2008.08717.x
- 11. Maeda K, Fukuda M. Arbutin: mechanism of its depigmenting action in human melanocyte culture. J Pharmacol Exp Ther. 1996;276(2):765-9.
- 12. Monteiro RC, Kishore BN, Bhat RM, Sukumar D, Martis J, Ganesh HK. A comparative study of the efficacy of 4% hydroquinone vs 0.75% Kojic acid cream in the treatment of facial melasma. Indian J Dermatol. 2013;58(2):157.10.4103/0019-5154.108070365722723716817
- 13. Wu S, Shi H, Wu H, Yan S, Guo J, Sun Y, et al. Treatment of melasma with oral administration of tranexamic acid. Aesthetic Plast Surg. 2012;36(4):964-70.10.1007/s00266-012-9899-922552446
- 14. Karn D, Kc S, Amatya A, Razouria EA, Timalsina M. Oral tranexamic acid for the treatment of melasma. Kathmandu Univ Med J (KUMJ). 2012;10(4):40-3.10.3126/kumj.v10i4.1099323575051
- 15. Grover C, Reddu BS. The therapeutic value of glycolic acid peels in dermatology. Indian J Dermatol Venereol Leprol. 2003;69(2):148-50.
- 16. Kumari R, Thappa DM. Comparative study of trichloroacetic acid versus glycolic acid chemical peels in the treatment of melasma. Indian J Dermatol Venereol Leprol. 2010;76(4):447.10.4103/0378-6323.6660220657143
- 17. Wattanakrai P, Mornchan R, Eimpunth S. Low‐fluence Q‐switched neodymium‐doped yttrium aluminum garnet (1,064 nm) laser for the treatment of facial melasma in Asians. Dermatol Surg. 2010;36(1):76-87.10.1111/j.1524-4725.2009.01383.x20298254
- 18. Manaloto RM, Alster T. Erbium: YAG laser resurfacing for refractory melasma. Dermatol Surg. 1999;25(2):121-3.10.1046/j.1524-4725.1999.08103.x10037517
- 19. Lee HS, Won CH, Lee DH, An JS, Chang HW, Lee JH, et al. Treatment of melasma in Asian skin using a fractional 1,550-nm laser: an open clinical study. Dermatol Surg. 2009;35(10):1499-504.10.1111/j.1524-4725.2009.01264.x19674038
- 20. Tamega Ade A, Miot LD, Bonfietti C, Gige TC, Marques ME, Miot HA. Clinical patterns and epidemiological characteristics of facial melasma in Brazilian women. J Eur Acad Dermatol Venereol. 2013;27(2):151-6.10.1111/j.1468-3083.2011.04430.x22212073
- 21. Lutfi RJ, Fridmanis M, Misiunas AL, Pafume O, Gonzalez EA, Villemur JA, et al. Association of melasma with thyroid autoimmunity and other thyroidal abnormalities and their relationship to the origin of the melasma. J Clin Endocrinol Metab. 1985;61(1):28-31.10.1210/jcem-61-1-283923030
- 22. Zoccali G, Piccolo D, Allegra P, Giuliani M. Melasma treated with intense pulsed light. Aesthetic Plast Surg. 2010;34(4):486-93.10.1007/s00266-010-9485-y20225000